Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | TYMP | P19971 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.44 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6632608 | 0.98 | KDM4E (0.69) | KDM4EALDH1A1LMNANPC1TYMP | |
| SCHEMBL4978570 | 0.90 | KDM4E (0.68) | KDM4EALDH1A1LMNANPC1TYMP | |
| SCHEMBL9872008 | 0.82 | KDM4E (0.61) | KDM4EALDH1A1LMNANPC1MAPT | |
| SCHEMBL11736480 | 0.81 | KDM4E (0.49) | KDM4EALDH1A1TYMPMAPTNPSR1 | |
| SCHEMBL17271402 | 0.81 | KDM4E (0.49) | KDM4EALDH1A1TYMPMAPTPKM | |
| SCHEMBL648709 | 0.80 | TYMP (0.67) | KDM4EALDH1A1TYMPMAPTPKM | |
| SCHEMBL14502537 | 0.79 | ALDH1A1 (0.49) | KDM4EALDH1A1TYMPPKMFFAR3 | |
| SCHEMBL17271400 | 0.76 | L3MBTL1 (0.56) | KDM4EALDH1A1TYMPMAPTNPSR1 | |
| SCHEMBL11449106 | 0.74 | ALDH1A1 (0.65) | KDM4EALDH1A1LMNANPC1NPSR1 | |
| SCHEMBL7134419 | 0.72 | KDM4E (0.54) | KDM4EALDH1A1LMNANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9875904-B2 | Silicon etching liquid, silicon etching method, and microelectromechanical element | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-01-23 | — | — | US | claimed |
| US-20150340241-A1 | SILICON ETCHING LIQUID, SILICON ETCHING METHOD, AND MICROELECTROMECHANICAL ELEMENT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-11-26 | — | — | US | claimed |
| US-20240307394-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2024-09-19 | — | — | US | disclosed |
| US-9875904-B2 | Silicon etching liquid, silicon etching method, and microelectromechanical element | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-01-23 | — | — | US | disclosed |
| US-20150340241-A1 | SILICON ETCHING LIQUID, SILICON ETCHING METHOD, AND MICROELECTROMECHANICAL ELEMENT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-11-26 | — | — | US | disclosed |
| US-8119665-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2012-02-21 | — | — | US | disclosed |
| US-20070208048-A1 | New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2007-09-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1490343-A1 | NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS | Neurogen Corporation (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040116424-A1 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION | 2004-06-17 | — | — | US | disclosed |
| WO-2003082829-A1 | NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS | NEUROGEN CORPORATION (US) | 2003-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208048-A1 | New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators | C3AR1, C5AR1, C5AR2 | KDM4E 2551/4885ALDH1A1 3370/4885LMNA 4797/4885 |
| US-20240307394-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D AND RELATED PRODUCTS AND METHODS | MRGPRX1, MRGPRX4, MRGPRX2 | KDM4E 4555/4885ALDH1A1 3659/4885LMNA 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.